Reactive Pneumocytes Identified by Distinctive Cytology
|
By LabMedica International staff writers Posted on 15 Apr 2020 |

Image: Touch preparation smears from cases of various forms of lung injury with reactive pneumocytes, illustrating markedly enlarged and highly atypical epithelial cells retaining distinctive Napoleon hat–like shapes (Photo courtesy of Natasha Rekhtman, MD, PhD).
One of the most challenging and exceedingly common diagnostic dilemmas in pulmonary pathology is the distinction between reactive and neoplastic epithelial atypia. In particular, reactive pneumocytes in various infectious or inflammatory lung diseases can exhibit marked cytological atypia, which can closely resemble malignancy.
Various types of acute and subacute lung injury can cause severe reactive pneumocyte atypia, which may mimic malignant proliferations and present a major diagnostic pitfall. This particularly applies to cytological preparations and frozen sections, where background inflammatory injury may be subtle or not apparent.
A pathologist at the Memorial Sloan Kettering Cancer Center (New York, NY, USA) has written that the most severe reactive pneumocyte atypia occurs in florid diffuse alveolar damage, where in the organizing phase, hyaline membranes are associated with markedly atypical pneumocytes. Key morphologic features of reactive pneumocytes in acute/subacute lung injury include marked cytomegaly, prominent nucleoli, and chromatin irregularities (clumping or clearing). Macronucleoli, of the type seen in melanomas or viral cytopathic effects, can be present. Nuclear contours may become focally irregular, but tend to remain smooth. Overdiagnosis of reactive pneumocytes as in adenocarcinoma is well documented in the literature. Some reactive pneumocytes have dense cytoplasm, which may also mimic squamous cell carcinoma.
Of particular note was one under recognized but extremely helpful cytomorphological clue to reactive pneumocytes in acute/subacute lung injuries is their highly distinctive shape, characterized by an elongated/pinched outline with a flat surface on one side and a convex surface with protruding nucleus on the opposite side. The flat surface corresponds to the area where the pneumocytes are plastered against the alveolar wall, whereas the convex surface corresponds to the area protruding into the airspaces. Even though the relationship of reactive pneumocytes to alveolar walls is usually not evident in dispersed cytological preparations or may be obscured in frozen sections and some small biopsies, this distinctive shape of reactive pneumocytes tends to be preserved in such specimens.
This shape evokes the look of Napoleon Bonaparte's iconic headwear; the bicorne (2-cornered) hat, thus prompting the proposed term of a “Napoleon hat” sign. Unlike reactive proliferations, the Napoleon hat shapes are only rarely encountered in carcinomas. Although lepidic adenocarcinomas do feature rows of neoplastic pneumocytes growing along alveolar walls, those cells characteristically have cuboidal/hobnail rather than elongated/pinched shapes.
Notably, Napoleon hat shapes tend to be well preserved in direct smears from fine-needle aspirates and touch preparations of core biopsies, whereas in bronchioloalveolar lavage fluids, cells tend to get rounded off, and this feature appears to be more subtle, but still evident in some cells. In frozen section and small biopsies, Napoleon hat shapes may also provide a useful clue to a reactive nature of epithelial atypia. The study was published in the April 2020 issue of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
Memorial Sloan Kettering Cancer Center
Various types of acute and subacute lung injury can cause severe reactive pneumocyte atypia, which may mimic malignant proliferations and present a major diagnostic pitfall. This particularly applies to cytological preparations and frozen sections, where background inflammatory injury may be subtle or not apparent.
A pathologist at the Memorial Sloan Kettering Cancer Center (New York, NY, USA) has written that the most severe reactive pneumocyte atypia occurs in florid diffuse alveolar damage, where in the organizing phase, hyaline membranes are associated with markedly atypical pneumocytes. Key morphologic features of reactive pneumocytes in acute/subacute lung injury include marked cytomegaly, prominent nucleoli, and chromatin irregularities (clumping or clearing). Macronucleoli, of the type seen in melanomas or viral cytopathic effects, can be present. Nuclear contours may become focally irregular, but tend to remain smooth. Overdiagnosis of reactive pneumocytes as in adenocarcinoma is well documented in the literature. Some reactive pneumocytes have dense cytoplasm, which may also mimic squamous cell carcinoma.
Of particular note was one under recognized but extremely helpful cytomorphological clue to reactive pneumocytes in acute/subacute lung injuries is their highly distinctive shape, characterized by an elongated/pinched outline with a flat surface on one side and a convex surface with protruding nucleus on the opposite side. The flat surface corresponds to the area where the pneumocytes are plastered against the alveolar wall, whereas the convex surface corresponds to the area protruding into the airspaces. Even though the relationship of reactive pneumocytes to alveolar walls is usually not evident in dispersed cytological preparations or may be obscured in frozen sections and some small biopsies, this distinctive shape of reactive pneumocytes tends to be preserved in such specimens.
This shape evokes the look of Napoleon Bonaparte's iconic headwear; the bicorne (2-cornered) hat, thus prompting the proposed term of a “Napoleon hat” sign. Unlike reactive proliferations, the Napoleon hat shapes are only rarely encountered in carcinomas. Although lepidic adenocarcinomas do feature rows of neoplastic pneumocytes growing along alveolar walls, those cells characteristically have cuboidal/hobnail rather than elongated/pinched shapes.
Notably, Napoleon hat shapes tend to be well preserved in direct smears from fine-needle aspirates and touch preparations of core biopsies, whereas in bronchioloalveolar lavage fluids, cells tend to get rounded off, and this feature appears to be more subtle, but still evident in some cells. In frozen section and small biopsies, Napoleon hat shapes may also provide a useful clue to a reactive nature of epithelial atypia. The study was published in the April 2020 issue of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
Memorial Sloan Kettering Cancer Center
Latest Pathology News
- Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
- First-Of-Its-Kind Test Identifies Autism Risk at Birth
- AI Algorithms Improve Genetic Mutation Detection in Cancer Diagnostics
- Skin Biopsy Offers New Diagnostic Method for Neurodegenerative Diseases
- Fast Label-Free Method Identifies Aggressive Cancer Cells
- New X-Ray Method Promises Advances in Histology
- Single-Cell Profiling Technique Could Guide Early Cancer Detection
- Intraoperative Tumor Histology to Improve Cancer Surgeries
- Rapid Stool Test Could Help Pinpoint IBD Diagnosis
- AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
- Deep Learning–Based Method Improves Cancer Diagnosis
- ADLM Updates Expert Guidance on Urine Drug Testing for Patients in Emergency Departments
- New Age-Based Blood Test Thresholds to Catch Ovarian Cancer Earlier
- Genetics and AI Improve Diagnosis of Aortic Stenosis
- AI Tool Simultaneously Identifies Genetic Mutations and Disease Type
- Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







